$1.1 Billion is the total value of Column Group LLC's 7 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NGM | New | NGM Biopharmaceuticals Inc | $466,502,000 | – | 15,396,116 | +100.0% | 42.31% | – |
| NRIX | New | Nurix Therapeutics Inc | $177,004,000 | – | 5,383,333 | +100.0% | 16.06% | – |
| ORIC | New | ORIC Pharmaceuticals Inc. | $161,403,000 | – | 4,768,181 | +100.0% | 14.64% | – |
| RVMD | New | Revolution Medicines Inc | $141,742,000 | – | 3,580,252 | +100.0% | 12.86% | – |
| RAPT | New | RAPT Therapeutics Inc | $76,742,000 | – | 3,885,679 | +100.0% | 6.96% | – |
| CNST | New | Constellation Pharmaceuticals Inc. | $75,647,000 | – | 2,626,631 | +100.0% | 6.86% | – |
| GRTS | New | Gritstone Oncology Inc | $3,426,000 | – | 869,493 | +100.0% | 0.31% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | 12 | Q3 2023 | 52.5% |
| Revolution Medicines Inc | 12 | Q3 2023 | 36.3% |
| RAPT Therapeutics Inc | 12 | Q3 2023 | 29.6% |
| ORIC Pharmaceuticals Inc. | 12 | Q3 2023 | 14.6% |
| Tenaya Therapeutics, Inc. | 9 | Q3 2023 | 24.2% |
| Surrozen, Inc. | 9 | Q3 2023 | 8.2% |
| eFFECTOR Therapeutics Inc | 9 | Q3 2023 | 6.9% |
| Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 12.6% |
| Nurix Therapeutics Inc | 2 | Q1 2021 | 16.1% |
| Gritstone Oncology Inc | 1 | Q4 2020 | 0.3% |
View Column Group LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 4 | 2022-05-27 |
| 4 | 2022-05-25 |
| 13F-HR | 2022-05-16 |
View Column Group LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.